跳至主要内容
临床试验/IRCT20150310021420N5
IRCT20150310021420N5招募中3 期

Effect of simultanious administration of FSH and hCG for triggering on oocyte quality and ART outcome in antagonist protocol

Tehran University of Medical Sciences0 个研究点目标入组 110 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
110

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 38 years(—)
性别
Female

入选标准

  • age between 18 and 38
  • third day FSH below10IU/ml and AFC more than 5 in each ovary
  • normal uterine cavity
  • antagonist protocol IVF cycles

排除标准

  • Estradiol at day of trigger more than 4500IU/l
  • Cancellation of oocyte retrieval due to cycle cancellation or changing to IUI
  • History of more than 2 failed IVF/ICSI
  • Severe male factor

研究者

相似试验

FSH administration for triggering final oocyte... | 临床试验